Your browser doesn't support javascript.
loading
A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer.
Lu, Yen-Shen; Lee, Keun Seok; Chao, Tsu-Yi; Tseng, Ling-Ming; Chitapanarux, Imjai; Chen, Shin-Cheh; Liu, Chien-Ting; Sohn, Joohyuk; Kim, Jee Hyun; Chang, Yuan-Ching; Yang, Youngsen; Shotelersuk, Kanjana; Jung, Kyung Hae; Valenti, Roberta; Slader, Cassandra; Gao, Melissa; Park, Yeon Hee.
Afiliação
  • Lu YS; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Lee KS; Center for Breast Cancer, National Cancer Center, Goyang, Republic of Korea.
  • Chao TY; Division of Hematology/Oncology, Shuang Ho Hospital and Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.
  • Tseng LM; Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Chitapanarux I; School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Chen SC; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Liu CT; Breast Surgery Division, Chang Gung Memorial Hospital, Linkou, Taoyouan City, Taiwan.
  • Sohn J; Division of Hematology and Oncology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan.
  • Kim JH; Division of Medical Oncology, Yonsei Cancer Center, Seoul, South Korea.
  • Chang YC; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
  • Yang Y; Department of Surgery, Mackay Memorial Hospital, Taipei, Taiwan.
  • Shotelersuk K; Taichung Veterans General Hospital, Taichung, Taiwan.
  • Jung KH; Division of Therapeutic Radiology and Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Valenti R; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Slader C; Novartis Pharma AG, Basel, Switzerland.
  • Gao M; Novartis Pharma AG, Basel, Switzerland.
  • Park YH; Novartis Pharma AG, Basel, Switzerland.
Clin Cancer Res ; 27(2): 408-417, 2021 01 15.
Article em En | MEDLINE | ID: mdl-32718997
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article